Secondary primary malignancies in patients with multiple myeloma: A single institution experience.

Fei, Fei; Reddy, Vishnu; Rosenblum, Frida

Fei, Fei; Reddy, Vishnu; Rosenblum, Frida.

Affiliation

Fei F; Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
Reddy V; Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
Rosenblum F; Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

Hematol Oncol ; 39(5): 674-679, 2021 Dec.

Article in En | MEDLINE | ID: mdl-34510500

Subject(s)

Hematopoietic Stem Cell Transplantation/adverse effects; Multiple Myeloma/therapy; Neoplasms, Second Primary/epidemiology; Adult; Aged; Aged, 80 and over; Alabama/epidemiology; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Multiple Myeloma/pathology; Neoplasms, Second Primary/etiology; Neoplasms, Second Primary/pathology; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Transplantation, Autologous

Key words

multiple myeloma; myelodysplastic syndrome; overall survival; secondary primary malignancies

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Neoplasms, Second Primary / Hematopoietic Stem Cell Transplantation / Multiple Myeloma Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Hematol Oncol Year: 2021 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google